AXIM Biotechnologies, Inc. (OTCMKTS:AXIM – Get Free Report) was the recipient of a large increase in short interest in the month of May. As of May 15th, there was short interest totaling 16,547 shares, an increase of ∞ from the April 30th total of 0 shares. Based on an average daily volume of 130,387 shares, the short-interest ratio is presently 0.1 days.
AXIM Biotechnologies Stock Performance
Shares of OTCMKTS:AXIM opened at $0.01 on Monday. The firm has a fifty day moving average price of $0.01 and a 200 day moving average price of $0.01. AXIM Biotechnologies has a 1-year low of $0.00 and a 1-year high of $0.03.
AXIM Biotechnologies Company Profile
AXIM Biotechnologies, Inc is a development-stage biotechnology company focused on the research, development and commercialization of cannabinoid-based technologies. The company’s primary objective is to advance formulations and delivery systems for cannabidiol (CBD) and other cannabinoids, targeting applications in nutraceuticals, skincare and medical devices. Through its proprietary encapsulation and atomization techniques, AXIM aims to enhance the bioavailability and stability of cannabinoid compounds for consumer and clinical use.
The company’s product pipeline includes novel CBD-infused nutraceuticals designed to promote general wellness, as well as specialized formulations for topical and inhalation delivery.
Featured Stories
- Five stocks we like better than AXIM Biotechnologies
- These 3 CLO ETFs Target a Niche Corner of the Fixed-Income Market
- 3 Ways to Play the Data Center Land Grab
- The Smarter Way to Invest in AI Without Taking Extreme Risk
- 3 Dividend Kings That Earn Their Crown Every Quarter
Receive News & Ratings for AXIM Biotechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXIM Biotechnologies and related companies with MarketBeat.com's FREE daily email newsletter.
